References
- Grootendorst P, Piérard E, Shim M. Life-expectancy gains from pharmaceutical drugs: a critical appraisal of the literature. Expert Rev. Pharmacoeconomics Outcomes Res.9(4), 353–364 (2009); Corrigendum: 9(5), 492 (2009).
- Lichtenberg F. Pharmaceutical knowledge – capital accumulation and longevity. In: Measuring Capital in the New Economy. Corrado C, Haltiwanger J, Sichel D (Eds). University of Chicago Press, IL, USA, 237–269 (2005).
- Lichtenberg FR. Sources of U.S. longevity increase, 1960–2001. Q. Rev. Econ. Finance44, 369–389 (2004).
- Angrist JD, Pischke J. Mostly Harmless Econometrics: an Empiricist’s Companion. Princeton University Press, NJ, USA (2008).
- Cutler DM, Long G, Berndt ER et al. The value of antihypertensive drugs: a perspective on medical innovation. Health Affairs26(1), 97–110 (2007).
- Cutler DM. Your Money or Your Life: Strong Medicine for America’s Health Care System. Oxford University Press, Oxford, UK (2004).
Websites
- Pear R. US to compare medical treatments. New York Times 9 February 2009 www.nytimes.com/2009/02/16/health/policy/16health.html
- The ALLHAT study of the efficacy of different anti-hypertensive drugs www.nhlbi.nih.gov/health/allhat/facts.htm
- The WHI study of postmenopausal hormone therapy www.nhlbi.nih.gov/whi/